A new study said Merck's widely used antiviral Covid pill can cause mutations in the virus that occasionally spread to other people. But there is no evidence that molnupiravir, sold under the brand ...

Since the emergence of SARS-CoV-2 in 2019, the virus has accrued a variety of mutations to infect its human hosts more effectively. Certain antiviral treatments work by increasing the rate of these ...

With every new infection, the pandemic coronavirus gets new chances to mutate and adapt, creating opportunities for the virus to evolve new variants that are better at dodging our immune systems and ...

Molnupiravir, an antiviral drug used to treat patients with COVID-19, appears to be driving SARS-CoV-2 to mutate and evolve, with some of these new viruses being transmitted onwards, a new study has ...

A single mutation stands in the way of a drug's effectiveness. Understanding it helps find new therapeutic approaches. So far, there are no specific drugs to treat the hepatitis E virus. Doctors only ...

A drug used to treat covid-19 appears to be driving the evolution of the SARS-CoV-2 coronavirus, according to an analysis of the 15 million viruses sequenced around the world so far. The analysis ...

An antiviral drug that was granted an emergency use authorization by the U.S. Food and Drug Administration in December 2021 may be linked to mutations in the virus, according to a new study released ...

The findings may increase scrutiny about the usefulness of the treatment, molnupiravir, which was one of the first Covid drugs available to doctors worldwide during the pandemic. Molnupiravir works by ...